109 related articles for article (PubMed ID: 28532694)
1. Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America.
Chan AJ; Balderramo D; Kikuchi L; Ballerga EG; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Ferrer JD; Yang JD; Carrera E; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR; Debes JD
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1631-1632. PubMed ID: 28532694
[No Abstract] [Full Text] [Related]
2. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America.
Cano L; Cerapio JP; Ruiz E; Marchio A; Turlin B; Casavilca S; Taxa L; Marti G; Deharo E; Pineau P; Bertani S
Sci Rep; 2018 Jul; 8(1):9945. PubMed ID: 30061721
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B.
Yang JD; Gyedu A; Afihene MY; Duduyemi BM; Micah E; Kingham TP; Nyirenda M; Nkansah AA; Bandoh S; Duguru MJ; Okeke EN; Kouakou-Lohoues MJ; Abdo A; Awuku YA; Ajayi AO; Omonisi AE; Ocama P; Malu AO; Mustapha S; Okonkwo U; Kooffreh-Ada M; Debes JD; Onyekwere C; Ekere F; Rufina I; Roberts LR;
Am J Gastroenterol; 2015 Nov; 110(11):1629-31. PubMed ID: 26618430
[No Abstract] [Full Text] [Related]
5. HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma.
Kim JH; Lee YS; Lee HJ; Yoon E; Jung YK; Jong ES; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
J Clin Gastroenterol; 2011 Jan; 45(1):64-8. PubMed ID: 20535028
[TBL] [Abstract][Full Text] [Related]
6. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
[TBL] [Abstract][Full Text] [Related]
7. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection.
Wen WH; Chang MH; Hsu HY; Ni YH; Chen HL
J Pediatr; 2004 Mar; 144(3):397-9. PubMed ID: 15001956
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of hepatocellular carcinoma in chronic infection with hepatitis B].
Ntagirabiri R; Munezero B; Kaze H; Ndirahisha E; Manirakiza S
Pan Afr Med J; 2015; 20():167. PubMed ID: 26113910
[TBL] [Abstract][Full Text] [Related]
9. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.
Debes JD; Chan AJ; Balderramo D; Kikuchi L; Gonzalez Ballerga E; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Diaz Ferrer J; Yang JD; Carrera E; Garcia JA; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR
Liver Int; 2018 Jan; 38(1):136-143. PubMed ID: 28640517
[TBL] [Abstract][Full Text] [Related]
11. Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan.
Hung GY; Horng JL; Yen HJ; Lee CY; Lin LY
J Hepatol; 2015 Dec; 63(6):1390-6. PubMed ID: 26256438
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of HBV related hepatocellular carcinoma in Japan].
Nishiguchi S; Tamori A; Kuroki T; Oka H; Tanaka T; Monna T
Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):673-9. PubMed ID: 12442466
[No Abstract] [Full Text] [Related]
14. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
Ahn J; Lim JK; Lee HM; Lok AS; Nguyen M; Pan CQ; Mannalithara A; Te H; Reddy KR; Trinh H; Chu D; Tran T; Lau D; Leduc TS; Min A; Trong Le L; Bae H; Van Tran S; Do S; Hann HW; Wong C; Han S; Pillai A; Park JS; Tong M; Scaglione S; Woog J; Kim WR
Am J Gastroenterol; 2016 Sep; 111(9):1297-304. PubMed ID: 27325221
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study.
Fu SC; Huang YW; Wang TC; Hu JT; Chen DS; Yang SS
Aliment Pharmacol Ther; 2015 Jun; 41(11):1200-9. PubMed ID: 25846548
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and hepatitis B virus: family matters.
McMahon BJ
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1646-7. PubMed ID: 23735444
[No Abstract] [Full Text] [Related]
17. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B.
Konerman M; Loomba R
Aliment Pharmacol Ther; 2015 Jul; 42(1):117-8. PubMed ID: 26040518
[No Abstract] [Full Text] [Related]
18. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
Yuen MF; Tanaka Y; Fong DY; Fung J; Wong DK; Yuen JC; But DY; Chan AO; Wong BC; Mizokami M; Lai CL
J Hepatol; 2009 Jan; 50(1):80-8. PubMed ID: 18977053
[TBL] [Abstract][Full Text] [Related]
19. [Study on the natural history of chronic hepatitis B].
Wu G; Zhou W; Zhao Y; Guo S; Wang Z; Zou S; Zhang Q; Ren H; Huang A; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):46-8. PubMed ID: 11856503
[TBL] [Abstract][Full Text] [Related]
20. Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B.
Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
J Viral Hepat; 2018 May; 25(5):552-560. PubMed ID: 29194870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
